Lucia V Torian1, Lisa Forgione1, Joel O Wertheim2. 1. The New York City Department of Health and Mental Hygiene, HIV Epidemiology Program, Long Island City, New York, New York. 2. Department of Medicine, University of California San Diego, La Jolla, California, USA.
Abstract
OBJECTIVE: Unintentional drug poisoning and overdose deaths in New York City (NYC) increased 175% between 2010 and 2017, partly due to the transition from noninjectable opioids to heroin injection. This transition has led to concern of a resurgent HIV epidemic among persons who inject drugs (PWID) in NYC. Thus, we sought to characterize HIV transmission dynamics in PWID. DESIGN: Genetic network analysis of HIV-1 public health surveillance data. METHODS: We analyzed HIV diagnoses reported to public health surveillance to determine the trajectory of the HIV epidemic among PWID in NYC, from 1985 through 2019. Genetic distance-based clustering was performed using HIV-TRACE to reconstruct transmission patterns among PWID. RESULTS: The majority of the genetic links to PWID diagnosed in the 1980s and 1990s are to other PWID. However, since 2011, there has been a continued decline in new diagnoses among PWID, and genetic links between PWID have become increasingly rare, although links to noninjecting MSM and other people reporting sexual transmission risk have become increasingly common. However, we also find evidence suggestive of a resurgence of genetic links among PWID in 2018-2019. PWID who reported male-male sexual contact were not preferentially genetically linked to PWID over the surveillance period, emphasizing their distinct risk profile from other PWID. CONCLUSION: These trends suggest a transition from parenteral to sexual transmission among PWID in NYC, suggesting that harm reduction, syringe exchange programs, and legalization of over-the-counter syringe sales in pharmacies have mitigated HIV risk by facilitating well tolerated injection among new PWID.
OBJECTIVE: Unintentional drug poisoning and overdose deaths in New York City (NYC) increased 175% between 2010 and 2017, partly due to the transition from noninjectable opioids to heroin injection. This transition has led to concern of a resurgent HIV epidemic among persons who inject drugs (PWID) in NYC. Thus, we sought to characterize HIV transmission dynamics in PWID. DESIGN: Genetic network analysis of HIV-1 public health surveillance data. METHODS: We analyzed HIV diagnoses reported to public health surveillance to determine the trajectory of the HIV epidemic among PWID in NYC, from 1985 through 2019. Genetic distance-based clustering was performed using HIV-TRACE to reconstruct transmission patterns among PWID. RESULTS: The majority of the genetic links to PWID diagnosed in the 1980s and 1990s are to other PWID. However, since 2011, there has been a continued decline in new diagnoses among PWID, and genetic links between PWID have become increasingly rare, although links to noninjecting MSM and other people reporting sexual transmission risk have become increasingly common. However, we also find evidence suggestive of a resurgence of genetic links among PWID in 2018-2019. PWID who reported male-male sexual contact were not preferentially genetically linked to PWID over the surveillance period, emphasizing their distinct risk profile from other PWID. CONCLUSION: These trends suggest a transition from parenteral to sexual transmission among PWID in NYC, suggesting that harm reduction, syringe exchange programs, and legalization of over-the-counter syringe sales in pharmacies have mitigated HIV risk by facilitating well tolerated injection among new PWID.
Authors: Crystal M Fuller; Jennifer Ahern; Liza Vadnai; Phillip O Coffin; Sandro Galea; Stephanie H Factor; David Vlahov Journal: J Am Pharm Assoc (Wash) Date: 2002 Nov-Dec
Authors: Don C Des Jarlais; Kamyar Arasteh; Theresa Perlis; Holly Hagan; Abu Abdul-Quader; Douglas D Heckathorn; Courtney McKnight; Heidi Bramson; Chris Nemeth; Lucia V Torian; Samuel R Friedman Journal: AIDS Date: 2007-01-11 Impact factor: 4.177
Authors: Alexandra M Oster; Joel O Wertheim; Angela L Hernandez; Marie Cheryl Bañez Ocfemia; Neeraja Saduvala; H Irene Hall Journal: J Acquir Immune Defic Syndr Date: 2015-12-01 Impact factor: 3.731
Authors: Joel O Wertheim; Sergei L Kosakovsky Pond; Lisa A Forgione; Sanjay R Mehta; Ben Murrell; Sharmila Shah; Davey M Smith; Konrad Scheffler; Lucia V Torian Journal: PLoS Pathog Date: 2017-01-09 Impact factor: 6.823
Authors: Joel O Wertheim; Andrew J Leigh Brown; N Lance Hepler; Sanjay R Mehta; Douglas D Richman; Davey M Smith; Sergei L Kosakovsky Pond Journal: J Infect Dis Date: 2013-10-22 Impact factor: 5.226